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We performed a clinical, biochemical, and genetic study 
in 16 patients from 11 families with adult-onset acid 
maltase deficiency. All patients were compound hetero- 
zygotes and carried the IVS1( -- 13T+G) transversion on 
one alkele; the second allele harbored either a deletion 
of a T at position 525 in exon 2 (7 probands, 64%) or a 
deletion of exon 18 (1 probanid, 9%). Deterioration of 
handicap was related to age, arid decrease in vital capac- 
ity to duration of the symptomatic stage. Respiratory 
insufficiency was never the firlit manifestation. The lev- 
els of activity of serum creatine kinase and of a- 
glucosidase in peripheral blood cells or muscle were 
helpful for the diagnosis, but did not have prognostic 
value. The adult form of acid nnaltase deficiency appears 
to be both clinically and genetically rather homoge- 
neous; decrease of a-glucosidase activity is the final com- 
mon pathway leading to destruction of muscle fibers and 
progression of muscle weakness over a period of years. 
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Glycogen storage disease type 11, acid maltase defi- 
ciency (AMD), is caused by deficiency of the lysosomal 
enzyme acid a-glucosidase (GAA; synonym, acid malt- 
ase) [l-33, and is a heterogeneous autosomal recessive 
disease with three major phenotypes-infantile, juve- 
nile, and adult [2 ,  3). Adult-onset AMD may resemble 
polymyositis or limb-girdle muscular dystrophy [2-61. 
Identification of various mutations in the AMD gene 
could explain differences between and within the phe- 
notypes of AMD [Z}. The GAA gene contains 20 ex- 
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ons and has a length of approximately 20 kb [7, 8). 
Mutations in patients with AMD include missense, 
nonsense, and frameshift mutations [9). Three muta- 
tions seem to be frequent: a deletion of exon 18 (del 
exon 18) [lo, 1 I), a single base pair deletion (525delT) 
in exon 2 1121, and the IVS 1( - 13T+G) transversion 
in the consensus sequence of the acceptor splice site 
of intron I 1131. We tested patients with adult-onset 
AMD for these mutations and compared genotype 
with phenotype. 
Patients and Methods 
D N A  Analysis: Amplification and 
Mutation Detection 
High-molecular-weight D N A  was isolated from periph- 
eral blood leukocytes according to established procedures. 
The patients were specifically tested for the mutations 
IVS1( - 13T+G), 525delT and del exon 18 in the GAA 
gene using the polymerase chain reaction (PCR). The 
IVS I (  - 13T+G) transversion was analyzed with a PCR 
based on allele-specific amplification. The forward primers 
used were POMl3T (TCCCTGCTGTAGCCCGCTrr) for 
the normal sequence and POMl3G (CCTGCTGTAGCCC 
GCTTG) for the mutated allele. As reverse primer, 
POM 13R (TTGTCAGGGGCGCAATCGAA) was used in 
both reactions. The 525delT mutation was identified by a 
Ddel restriction analysis of the PCR product generated with 
the forward primer POM525F (AGAGCAGTGCCCACAC 
AGTG) and the reverse primer POM525R (GTGGGTGTC 
GATGTCCACGC). Del exon 18 was identified using the 
primers POM 17F (TGGnCCTGAGGACAGCATG) (for- 
ward) and POM18R (AGTGGCAGGTAGCCATCGTG) 
(reverse). The amplification was performed in 33 cycles, each 
cycle consisting of 1 minute of denaturation at 94"C, 1 min- 
ute of annealing at 55"C, and 2 minutes of extension at 7 2 T ,  
essentially as described elsewhere [ 141. 
Evuhation of Patients 
Sixteen adult-onset AMD patients from 1 1 unrelated families 
of Dutch Caucasian ancestry, diagnosed between 1982 and 
1994, were examined in the summer of 1994 by one of us 
(J.H.J.W.). We did manual muscle testing and calculated mo- 
tor sum scores. Handicap was scored using the modified Ran- 
kin scale [15}. Vital capacity (VC) was measured in 1994. 
Three patients (Patients 1, 2, and 6) were only questioned 
about symptoms and handicap. The following laboratory 
tests were performed: measurement of blood creatine kinase 
(CK) activity, electromyography (EMG), electrocardiography 
(EKG), and measurement of GAA activity in peripheral 
blood lymphocytes and leukocytes using glycogen as sub- 
strate at p H  4,  and in muscle with the methylumbelliferyl 
substrate [l6]. Skeletal muscle biopsy specimens from 11 
patients were prepared for light microscopy using routine 
methods for histology and histochemistry of cryostat sec- 
tions. In 1994 residual activity of GAA was measured in 9 
biopsy specimens. 
Statistical Analysis 
The motor sum scores of upper and lower limbs were com- 
pared using the nonparametric Wilcoxon matched-pairs 
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Fig  1. Agarose gel electrophoresis of the lVSl ( -  1 3 T j G )  al- 
lele-specz$c polymerase chain reaction (PCR) products of 12 pa- 
tients with adult-onset acid maltase deficiency (AMD) (lanes 
1-3 and 7-15), Lanes 4 to  6 show the products of infantile 
AMD putients which served as controls. The PCR products for 
the two alleles are approximately of the same size (35 1 bp for 
the T allele, 349 for the AMD G allele). The two PCRs under- 
went electrophoresis consecutively within a period of 1 hour. The 
molecular weight marker (M j for the T allele is shown on the 
left, for the G allele on the right. 
signed rank test and the p value was calculated as a two-tailed 
test. In patients with various degrees of handicap, we tested 
differences of age, CK activity, and residual activity of GAA 
using analysis of variance (ANOVA) and Student’s t test. 
These tests were also used to assess differences between du- 
ration of disease and VC. 
Results 
D N A  Analysis 
Patients of 11 families with adult-onset AMD were 
screened for three mutations: IVSl( -- 13T-G) [13], 
525delT [12], and del exon 18 [lo, 1 I]. Genetic test- 
ing for the IVS 1( - 13T+G) transversion identified all 
patients with adult AMD as compound heterozygotes 
as they had amplification of both the normal T allele 
and the AMD G allele (Fig. 1). Seven patients had 
525delT as second mutation; in 1 proband del exon 
18 was detected. Three patients did not show either 
the 525delT or the del exon 18. To prove that indeed 
the mutations are located on different alleles, we fol- 
lowed the segregation of the gene defects in the fami- 
lies. Figure 2 depicts an example of the analyses for two 
compound heterozygotes: IVSl( - 13T-G); 525delT, 
respectively, IVS1( - 13T+G); del exon 18. Analysis 
of the parents of all patients who were compound het- 
erozygotes for the above mutations (Table; Patients 
1-10, 15, and 16) showed that the mutations were on 
separate alleles. 
Clinical Abnomnalities 
At the initial examination, 3 young adults had no symp- 
toms or  signs; 2 had an affected sibling and 1 was re- 
ferred for hyper-CK-emia. The age at onset of com- 
plaints in the other 13 patients varied between 17 and 
45 years (mean, 31 years). The presenting symptoms 
were abnormal fatigue in 5 patients and proximal weak- 
ness of the legs in 8. The standard neurological exami- 
nation at the time of diagnosis revealed normal findings 
in 4 patients with complaints. In the others we found 
symmetrical proximal weakness of the flexor muscles 
of the hips and knees. After a follow-up period of 1 
to 13 years (mean, 6 years), 2 patients remained asymp- 
tomatic. Deterioration of proximal muscle weakness 
always occurred gradually except in Patient 14, who at 
the age of 39 had acute respiratory insufficiency during 
a respiratory tract infection. At the end of the fol- 
low-up period, weakness was found in 11 of 13 pa- 
tients; the motor sum scores of the upper limbs ranged 
between 24 and 30 (median, 28) and those of the lower 
limbs between 21 and 30 (median, 24; p < 0.03). The 
mean age of 4 patients with handicap grade 0 or 1 on 
the modified Rankin scale was 22 k 4 years; of 6 
patients with grade 2, 40 -+ 10 years; and of 6 patients 
with grade 3 or 4, 47 -t 7 years (see Table). The 
difference between the younger and the two older 
groups was significant ( p  < 0.005). VC was decreased 
in 11 (77’33) of 14 examined patients. After a symp- 
tomatic stage of 1 to 5 years, mean VC was 96 ~fr 6%; 
after 6 to 10 years, mean VC was 69 t 14%; and 
after 11 to 15 years, mean VC was 53 k 25%. The 
difference between the first and the other two groups 
was significant ( p  < 0.005). 
Labomtory Analysis 
CK elevation ranged between 1.5 and 15 times and 
was not related to severity of handicap. The EKG only 
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Clinical, Biochemical, and Genetic Characteristics of I 6  Adult Patients with Acid Maltase DeJcienc? 
Patient No. 
1 2 3 4  5 6  7 8  9 10 11 12 13 14 1 5  16 
Pedigree A A B C D E E F F G H H I J K K  
Sex F M F E  M F  M F  F M F  F M M F F  
Age atdiagnosis (yr) 18 19 52 24 19 41 41 24 36 45 33 24 15 39 47 42 
Ageatevaluation(yr) 23 2 1  58 37 21 49  50 28 40 46 37 33 19 45 58 49 
525delT + + + +  + +  + +  + + -  
IVS1( - 13T+G) + + + +  + +  + +  + + +  + + + + +  
+ +  Del exon 18 
Vital capacity (%) ND 101 30 100 92 ND 49 103 80 84 87 90 92 30 64 69 
Rankin score 2 1 4 2  0 2  3 0  3 2 2  3 1 2 3 3  
GAAinleukocytes" 42 50 36 20 5 1  21 5 5  48 41 4 3  53 59 14 36 33 45 
GAAinlymphocytes" 41 51 53 ND 36 ND 39 52 44 40 32 31 2 39 26 15 
GAA in muscleJ 1 1  ND 21 ND ND ND 21 ND ND 9 ND 30 7 16 9 4 
- - _ - _  
- -  - _ -  - - - -  - -  - -  - 
~ 
"a-Glucosidase (GAA) values as mea:mred in peripheral blood leukocytes, lymphocytes, and muscle; values given are percentage of lower limits 
in healthy controls. 
ND = not done. 
was abnormal in Patient 10 who had had a myocardial 
infarction at the age of 43 years. EMG showed myo- 
pathic changes in 8 of 13 patients; 1 of 6 patients had 
a normal EMG including analysis of erector spinal mus- 
cles. Skeletal muscle biopsy specimens were histologi- 
cally and histochemically normal in 3 patients but in 
all specimens GAA activity was decreased (values be- 
tween 4 and 30%, [see Table]). GAA activity in pe- 
ripheral blood cells was decreased in all patients. 
Discussion 
All 11 probands and their affected siblings were 
compound heterozygotes; they carried the IVS 1 
( - 13T-G) mutation on one allele; the second allele 
harbored either 525delT (7 probands, 64%) or del 
exon 18 (1 proband, 9%). In 3 probands (27%), the 
second mutation has not been identified. We could 
identify mutations in 19 (869;) of the 22 alleles. Huie 
and coworkers [13] detected the IVS1( - 13T-G) 
transversion on one allele in 28 of 41 patients with 
adult-onset AMD. In the present study we found an 
allele frequency of 0.5 among probands. The 525delT 
was found in 7 of 11 probands (allele frequency, 0.32). 
This frameshift mutation reclently was described in 3 
patients with AMD E12). The del exon 18 mutation 
that we found in 1 proband is reported mostly in pa- 
tients with infantile-onset AMD {lo, ll]. The 525delT 
mutation has been associated with complete absence 
of GAA. Expression studies of the mutant complemen- 
tary D N A  in SV 40 transformed monkey kidney cells 
showed that the 525delT deletion prohibits the forma- 
tion of mature enzyme 1121. Del exon 18 is also a 
disastrous mutation, that is, associated with complete 
loss of enzyme activity (Ausems et al, unpublished 
data, 1995). The IVS1( - 13T-G) mutation is associ- 
ated with aberrant splicing of the pre-messenger RNA 
(mRNA): The exon 2 sequence is skipped from the 
GAA mRNA {13]. However, Huie and coworkers 
[13] showed that still some correctly spliced mRNA is 
present. Our studies confirmed this finding that the 
IVS1( - 13T+G) mutation can be considered as mild, 
as our patients all had a significant level of GAA activ- 
ity in peripheral blood cells. The phenotype of adult- 
onset AMD can be explained by the genotype, for 
example, the combination of one deleterious mutation 
with the milder mutation IVS1( - 13T-G). The resid- 
ual enzyme hypothesis may explain major differences 
between infantile and adult forms of AMD, but not 
within adult-onset AMD {2). The conclusion of adult- 
onset AMD being a mild, homogeneous limb-girdle 
dystrophy-like syndrome with very slow progression is 
favored by two arguments: First, young adults had ei- 
ther no symptoms or only abnormal fatigue, but were 
not handicapped, whereas older patients were more or 
less severely incapacitated. Second, during the fol- 
low-up period all patients showed deterioration. Respi- 
ratory insufficiency was never the first manifestation in 
Fig  2. Confirmation that the mutations I V S I ( -  13T-+G) and 
del exon 18 in Proband K and the IVS l (  - I3T-G) and 
525delT in Proband D are located on separate alleles. (A) The 
pedigree and the agarose gel electrophoresis for Proband K and 
her parents (C = nomzal polymerase chain reaction fragment 
without Ddeli. (B)  The analysis for Proband D (C = normal 
control). At the bottom of each panel, a schematic representation 
of the mutation analysis is indicated. The 525delT disrupts a 
Ddel site giving rije to  an additional f~agment of 189 bp 
(vertical bars represent the recognition site of Ddeli. Del exon 
18 is indicated by the appearance of a fragment with a reduced 
length of 390; the nomzal fragment has a length of 925 bp. 
The additional fragment between the two fragments is caused by 
heteroduplex formation between the opposite strands of the two 
alleles. 
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previously asymptomatic patients. This relatively mild 
appearance of the adult form of AMD is remarkable 
and can be explained by earlier referral of patients. In 
our department, AMD is diagnosed yearly in 1 or 2 
new patients. At present the frequency of the various 
mutations in the Dutch population is not known, but 
as 7 (64%) of 11 families showed the same combina- 
tion of mutations, adult-onset AMD appears to be ge- 
netically rather homogeneous in the Netherlands. 
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A Search for Human 
T-cell Leukemia Virus 
Type I in the Lesions of 
Patients with Tropical 
Spastic Paraparesis and 
Polymy ositis 
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RCmi Bellance, MD,? Vladimir Zaninovic, MD,S 
Luis Cartier, MD,§ Michel Brahic, MD, PhD," 
and Simona Ozden, PhD' 
We searched for the presence of human T-cell leukemia 
virus type I (HTLV-I) sequences in central nervous 
system and muscle lesions of 3 patients with tropical 
spastic paraparesis/HTLV-I-associated myelopathy 
(TSP/HAM) and 3 patients with HTLV-I-associated 
polymyositis. Proviral DNA coding for the Tax protein 
was found by polymerase chain reaction amplification 
in DNA extracted from lesions of every patient with 
TSP/HAM or HTLV-I-associated polymyositis. In con- 
trast, viral RNA was found occasionally by in situ hy- 
bridization in muscle lesions of some patients with poly- 
myositis, but was never found in central nervous system 
lesions of TSP/HAM patients. 
Tangy F, Vernant J-C, Coscoy L, Ossondo M, 
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Ozden S. A search for human T-cell leukemia virus 
type I in the lesions of patients with tropical 
spastic paraparesis and polymyositis. 
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